Melek Aslan Kayıran
Istanbul, Turkey (Türkiye)
NCT Number: NCT04207216
Psoriasis Vulgaris is a chronic, recurrent, inflammatory and hyperproliferative skin disease. Joint involvement is common along with skin involvement. However, metabolic diseases, such as cardiovascular diseases can be accompanied by many systemic diseases, chronic and repetitive due to the quality of life and psychological status of patients can affect. Today, although the treatment is repetitive, chronic and requires follow-up due to the disease patients can turn to alternative and complementary medicine techniques. In recent years, studies on alternative medicine and complementary therapies have been noted in the medical literature. These studies also include Case Reports related to psoriasis vulgaris. However, in our country, there is no study that tells us whether patients with psoriasis vulgaris apply these treatments or not and what the practitioners think about the success of the treatment. The aim of the study will be to clarify issues such as whether patients with Psoriasis Vulgaris apply alternative medicine and complementary therapies for their disease.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Istanbul, Turkey (Türkiye)
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: July 2020
Istanbul Medeniyet University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04306315
Psoriasis Vulgaris
Brussels, Belgium
View Trial DetailsNCT03372811
Psoriasis, Psoriasis Vulgaris
New York, United States
View Trial DetailsNCT04340076
Psoriasis, Psoriasis Vulgaris
Brussels, Belgium
View Trial DetailsNCT05442190
Plaque Psoriasis, Psoriasis
San Diego, California, United States
View Trial Details